France Legalises Assisted Dying: How the New End-of-Life Law Works and What Happens Next

France has officially enacted its landmark "aid in dying" legislation after receiving full approval from the Constitutional Council. While the law grants incurably ill adults the right to voluntary termination of life, strict eligibility rules, conscience clauses, and local access hurdles mean the real test for the healthcare system begins now.
Following its publication in the Journal Officiel on August 19, the law formally entered into force. It marks the end of a protracted legal process: Parliament passed the bill in July by 291 votes to 241, and the Constitutional Council cleared the text on August 14 despite challenges from senior political leaders.
The change is a major one. Until now, French law allowed doctors to stop life-sustaining treatment in certain cases and to use deep continuous sedation for terminally ill patients. It did not allow active assistance in dying.
France is now moving into a different legal territory. But it has done so cautiously, putting several layers of checks around the new right.
France has chosen a middle ground
The new system is not the same as the one operating in Belgium or the Netherlands, where doctors can administer life-ending medication under legal conditions. Nor does it follow exactly the Swiss or Canadian models.
In France, the patient must normally take the lethal substance themselves. A healthcare worker can administer it only if the patient is physically unable to do so.
Before getting to that point, the patient must meet several conditions. They must be an adult French citizen or long-term resident with a serious and incurable illness causing unbearable physical or psychological suffering. They must also be able to make a free and informed decision.
A doctor first checks whether the person meets the requirements. The request then goes through a multidisciplinary medical assessment.
Even after approval, the patient has to wait at least two days and confirm the decision again on the day of the procedure. They can change their mind at any time.
That makes the French system quite restrictive compared with some other countries.
The choice of self-administration also matters politically and medically. France allows doctors and other professionals to help make the procedure possible, but the final act normally remains with the patient.
It is a way of recognising personal choice without making doctors directly responsible for administering the lethal substance in every case.
Doctors and institutions can still refuse
The Constitutional Council's decision added another important part to the system.
Private and religious healthcare facilities can refuse to provide assisted dying if doing so would clearly conflict with their mission. There is one important condition: patients must still have access to the procedure elsewhere locally.
Individual healthcare workers also have the right to object.
The Council specifically extended that protection to pharmacists who prepare or dispense the lethal substances. Doctors and nurses were already covered.
There are additional safeguards for adults under legal protection. Doctors assessing their requests must take the observations of their legal guardians into account.
These rules show just how carefully France has tried to balance two competing ideas.
On one side is the patient's right to decide what happens to their own body. On the other is the right of doctors and religious healthcare organisations not to take part in something they consider morally wrong.
The difficult question is what happens when those two rights meet in places where there are few healthcare providers.
In a major city, a patient may have several hospitals or doctors to choose from. In a rural area, there may be far fewer options. If one facility refuses to provide assisted dying, finding another provider may not be simple.
The law says alternative access must be available locally. How that will work in practice is one of the questions that will only become clear once the system starts operating.
A major break with the old system
The change becomes clearer when compared with the 2016 Claeys-Leonetti law.
That legislation allowed doctors to withdraw or withhold life-sustaining treatment in certain circumstances. It also allowed continuous deep sedation until death for some terminally ill patients.
But it stopped short of allowing doctors or other healthcare professionals to actively help a patient die.
The new law crosses that line.
For French medicine, that is a significant change in the relationship between doctors and patients. The doctor is no longer simply helping someone live, manage pain or die without unnecessary treatment. Under certain conditions, the healthcare system can now help a person carry out a decision to end their life.
That is also why opponents see the law as more than a change to medical procedure.
The Conference of Bishops of France, Archbishop of Paris Laurent Ulrich, the Jérôme Lejeune Foundation and disability rights organisations have strongly opposed the legislation.
Their concern is that vulnerable people could feel pressure to choose death, particularly when they are elderly, disabled, seriously ill or facing long and expensive care.
That argument is likely to remain part of the French debate long after the political battle over the law is over.
Palliative care will remain a problem
One of the biggest questions is what alternatives patients will actually have.
Opponents of the law have argued that France should first guarantee proper access to palliative care. Their concern is straightforward: a person cannot make a completely free choice between continued life and assisted dying if good end-of-life care is not available.
This puts pressure on the government to make sure the new system does not become an answer to problems elsewhere in healthcare.
The law itself cannot solve that problem. It establishes when assisted dying can be provided. It does not automatically improve the availability of palliative care.
That leaves a difficult balance. France is giving patients a new legal choice while still having to make sure that choosing continued treatment and care is a realistic option.
The real test comes in 2027
The law may already be in force, but the system is not ready to operate everywhere.
Administrative decrees still have to be issued, setting out how the procedure will work in practice. The government expects implementation to begin in early 2027.
That is when many of the current legal questions will become practical ones.
Doctors will have to decide how the eligibility rules work in individual cases. Medical teams will have to assess requests. Pharmacists will have to decide whether they will participate or exercise their right to object.
Hospitals and other healthcare facilities that refuse to provide assisted dying will also have to work within the requirement that patients can still access it elsewhere locally.
This could become particularly sensitive in rural or conservative parts of France.
The French model was designed to avoid a direct clash between personal autonomy and freedom of conscience. But the two principles may be harder to keep apart once patients begin asking for the procedure.
Macron can already claim one important political success. Assisted dying was a major promise of his 2022 re-election campaign, and his government has now delivered it.
For people who support end-of-life choice, the law also removes the need for French citizens to travel abroad for assistance in dying, as some had previously done in Switzerland or Belgium.
For the Catholic Church and other opponents, the law is a clear defeat on the principle that life should never be deliberately ended through the healthcare system. Yet the new conscience protections give religious institutions and individual professionals a legal way to stay outside the practice.
France has therefore created a system in which both sides have been given something.
The patient gets a new legal right. The doctor can refuse to participate. A religious hospital can refuse as well. The state, meanwhile, has to make sure that refusal does not leave a qualifying patient without a realistic route to access.
That tension is now built into French law. The first real test will come not in Parliament or the Constitutional Council, but in the places where a patient has to find an actual doctor, hospital and pharmacist willing to make the new system work.
Sources: The Business Standard, rfi, The Guardian
